PBI14 COST-EFFECTIVENESS OF SECUKINUMAB VERSUS OTHER BIOLOGICS AND APREMILAST IN THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS: A SPANISH PERSPECTIVE
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.118
https://www.valueinhealthjournal.com/article/S1098-3015(19)32496-9/fulltext
Section Title :
Section Order :
10074
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32496-9&doi=10.1016/j.jval.2019.09.118